Faculty, Staff and Student Publications
Language
English
Publication Date
2-16-2024
Journal
Science Immunology
DOI
10.1126/sciimmunol.adj3945
PMID
38363830
PMCID
PMC11822965
PubMedCentral® Posted Date
2-13-2025
PubMedCentral® Full Text Version
Author MSS
Abstract
Stimulator of interferon genes (STING) is an immune adaptor protein that senses cyclic GMP-AMP (cGAMP) in response to self or microbial cytosolic DNA as a danger signal. STING is ubiquitously expressed in diverse cell populations including cancer cells with distinct cellular functions such as activation of type I interferons, autophagy induction, or triggering apoptosis. It is not well understood whether and which subsets of immune cells, stromal cells, or cancer cells are particularly important for STING-mediated antitumor immunity. Here using a polymeric STING-activating nanoparticle (PolySTING) with a “shock-and-lock” dual activation mechanism, we show type 1 conventional dendritic cell (cDC1) is essential for STING-mediated rejection of multiple established and metastatic murine tumors. STING status in the host but not in the cancer cells (Tmem173−/−) is important for antitumor efficacy. Specific depletion of cDC1 (Batf3−/−) or STING deficiency in cDC1 (XCR1creSTINGfl/fl) abolished PolySTING efficacy, whereas depletion of other myeloid cells had little effect. Adoptive transfer of wildtype cDC1 in Batf3−/− mice restored antitumor efficacy while transfer of cDC1 with STING or IRF3 deficiency failed to rescue. PolySTING induced a specific chemokine signature in wildtype but not Batf3−/− mice. Multiplexed immunohistochemistry analysis of STING-activating cDC1s in resected tumors correlates with patient survival while also showing increased expressions after neoadjuvant pembrolizumab therapy in non-small cell lung cancer patients. Therefore, we have defined that a subset of myeloid cells is essential for STING-mediated antitumor immunity with associated biomarkers for prognosis.
Keywords
Animals, Humans, Mice, Carcinoma, Non-Small-Cell Lung, Dendritic Cells, DNA, Interferon Type I, Lung Neoplasms, Nanoparticles, Immunotherapy, STING Protein, Antibodies, Monoclonal, Humanized
Published Open-Access
yes
Recommended Citation
Wang, Jian; Li, Suxin; Wang, Maggie; et al., "STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity" (2024). Faculty, Staff and Student Publications. 6729.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/6729
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons